SEATTLE--(BUSINESS WIRE)--LabConnect, LLC., a leading provider of central laboratory services to the biopharmaceutical industry, is listed as one of the fastest-growing private companies by the Deloitte Technology Fast 500, the Puget Sound Business Journal (PSBJ) and Inc. 5000.
“Receiving recognition for our growth within the life sciences industry reflects our dedication to simplifying and improving central laboratory services. Our business model is unique and successful for our clients,” said Eric Hayashi, president and CEO of LabConnect. “We continue to evaluate the needs of the industry and adapt and expand our services to support our clients as a one-stop shop.”
The Deloitte Technology Fast 500 is an annual ranking of the fastest-growing North American companies in the life sciences, technology, media, telecommunications and clean technology sectors. LabConnect qualified for this achievement based on its percentage of fiscal year revenue growth from 2009 to 2013.
This is LabConnect’s eighth appearance on the PSBJ’s annual list of the 100 fastest-growing private companies in Washington. The recognition is based on a recorded revenue of at least $500,000 in 2011 and demonstrated revenue growth through 2013. LabConnect revenues swelled by 84 percent between 2011 and 2013, which positions the company to triple in size over the next couple of years.
For the seventh time, LabConnect is on the Inc. 5000 fastest-growing private companies list, which ranks companies by overall revenue growth over a three-year period. This prestigious list is known as a showcase of entrepreneurial leaders.
“We’re honored to be acknowledged as one of the fastest-growing private companies,” said Hayashi. “Of our 120 clients located across the globe, more than 70 are repeat clients. As we prepare for growth, these clients will continue to be an integral part of our success.”
Founded in 2002, LabConnect provides global central laboratory services including routine and specialized laboratory testing, kit building, sample management, data management, biostorage and scientific support services for biopharmaceutical and CRO clients. LabConnect’s unique combination of state-of-the-art technology, world-class laboratories, easy access to emerging markets and extensive specialized testing expertise means the drug development industry can rely on one provider for all of their central laboratory service needs. Learn more at www.labconnectllc.com or connect with LabConnect on LinkedIn.